Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | MYC | P01106 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29731918 | 1.00 | TSHR (0.52) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL15351685 | 0.98 | TSHR (0.50) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL11231918 | 0.98 | TSHR (0.50) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL756585 | 0.84 | TSHR (0.61) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| Benzene SCHEMBL27265959 | 0.84 | TSHR (0.61) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL27703149 | 0.84 | TSHR (0.61) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL19834671 | 0.83 | BRPF1 (0.42) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL10768142 | 0.81 | TSHR (0.59) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL28188375 | 0.81 | TSHR (0.59) | TSHRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL27479457 | 0.81 | TSHR (0.59) | TSHRALDH1A1KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-112876403-B | Preparation method of apremilast impurity | 成都摩尔生物医药有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-112876403-A | Preparation method of apremilast impurity | 成都摩尔生物医药有限公司 | 2021-06-01 | — | — | CN | claimed |
| EP-3059220-B1 | METHOD OF PREPARING AND RECOVERING 2-METHYL-5-IODOBENZOIC ACID | ABA CHEMICALS CORP (CN) | 2018-12-05 | — | — | EP | claimed |
| US-10099981-B2 | Methods for meta-arylation of aromatic alcohols | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2018-10-16 | — | — | US | claimed |
| EP-3059220-A1 | METHOD OF PREPARING AND RECOVERING 2-METHYL-5-IODOBENZOIC ACID | ABA Chemicals Corporation (CN) | 2016-08-24 | — | — | EP | claimed |
| CN-103539662-B | Preparation and recovery method of 2-methyl-5-iodobenzoic acid | ABA CHEMICALS CORP | 2015-04-08 | — | — | CN | claimed |
| CN-103539662-A | Preparation and recovery method of 2-methyl-5-iodobenzoic acid | ABA CHEMICALS CORP | 2014-01-29 | — | — | CN | claimed |
| EP-1601642-A4 | BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX | RHEOGENE INC (US) | 2007-04-11 | — | — | EP | claimed |
| EP-1601642-A2 | BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX | RheoGene, Inc. (US) | 2005-12-07 | — | — | EP | claimed |
| WO-2004078924-A2 | BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX | RHEOGENE, INC. (US) | 2004-09-16 | — | — | WO | claimed |
| US-4328162-A | Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound | EASTMAN KODAK COMPANY (US) | 1982-05-04 | — | — | US | claimed |
| US-12569564-B2 | Spirocyclic MDM2 modulator and uses thereof | NEWAVE PHARMACEUTICAL INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-20260014260-A1 | MDM2 DEGRADER | NEWAVE PHARMACEUTICAL INC (US) | 2026-01-15 | — | — | US | disclosed |
| WO-2025262295-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | DARK BLUE THERAPEUTICS LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| EP-4667466-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | Dark Blue Therapeutics Ltd (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-0623123-A1 | BENZOPYRAN AND RELATED LTB4 ANTAGONISTS. | PFIZER (US) | 1994-11-09 | — | — | EP | disclosed |
| EP-0609625-A1 | Inhibitors of HIV protease useful for the treatment of AIDS | ELI LILLY AND COMPANY (US) | 1994-08-10 | — | — | EP | disclosed |
| WO-1993015067-A1 | BENZOPYRAN AND RELATED LTB4 ANTAGONISTS | PFIZER INC. (US) | 1993-08-05 | — | — | WO | disclosed |
| US-4328162-A | Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound | EASTMAN KODAK COMPANY (US) | 1982-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014260-A1 | MDM2 DEGRADER | MDM2, TP53, ADRM1 | TSHR 861/4885ALDH1A1 1614/4885KDM4E 3644/4885 |
| US-10099981-B2 | Methods for meta-arylation of aromatic alcohols | ADH1C, ADH1A, ADH5 | TSHR 2218/4885ALDH1A1 11/4885KDM4E 3165/4885 |
| US-12569564-B2 | Spirocyclic MDM2 modulator and uses thereof | MDM2, TP53, XIAP | TSHR 1018/4885ALDH1A1 1320/4885KDM4E 3943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.